Nanosphere (NSPH): Long Term Hold Potential
The prospects of Nanosphere (NSPH) look even juicier than Pizza the Hut from Spaceballs.
If you haven't heard of Nanosphere yet (and most investors have not), here is why they have great long term prospects:
Nanosphere is healthcare company which offers the "Verigene system", which is a diagnostic tool used to make diagnoses at the molecular level. NSPH recently received FDA approval for an assay for the early diagnosis of sepsis.
Sepsis is the leading cost of inpatient stay in the U.S. at over $15 billion annually, carrying a mortality rate of one in six patients.
Nanosphere is the only assay on the market that can provide broad identification of bacteria and drug resistance and a sample to result on-demand test. Recently cited publications demonstrated the benefit of reduced mortality in the intensive care unit from one in two patients to one in 10 as well as a 6.2 day reduction in length of stay saving over $21,000 per patient.
The Sepsis test addresses the clinical requirements for early diagnosis of sepsis, the number one driver of hospital costs and death.
Mastery Bottom Line:
Nanosphere is anything but a day trade. With a market cap of just $180m and Q2 2012 revenues of just $1.3 million, the company has a lot of room to grow. In Q2, before the FDA approval, they placed just 25 new Verigene systems.
If they can increase that number to 1,000 new Verigene systems a quarter over the coming years, revenues would increase to $25m a quarter. Management has plans to double the size of its sales and customer organization over the next few quarters, which should help provide the infrastructure they need to grow.
Best of the Blogs
Scanning and identifying the best blog entries every hour
- "No Going Back": Iraq Demands Exemption From Oil Production Cut, As Rosneft Slams Saudis | ZeroHedge
- Gold Market in Crisis, Risks Collapse: LBMA | Financial Sense
- Taliban Release Drone Film Of Suicide Attack In Afghanistan | ZeroHedge
- SNL Mocks Third Presidential Debate; Trump Silent On Twitter | ZeroHedge
- Losses Hurt More Than Gains | ZeroHedge
- Don Coxe: Raise Cash, Hold Gold | Financial Sense
- Goldman CEO Blankfein "Supportive" Of Hillary But "Doesn't Want To Hurt Her" By Endorsing | ZeroHedge
The most relevant financial news and articles from the Internets
- I tested these cheap Bluetooth headphones and was genuinely blown... | Business Insider
- Everything you need to know about refinancing your student loan debt | Business Insider
- Donald Trump promised to stop a proposed deal for AT&T to buy Time Warner if he wins... | Business Insider
- Why Japan has the best navy in Asia | Business Insider
- Mass prison break in Haiti: 174 inmates flee after... | Business Insider
- A former Stanford dean explains the simplest thing parents can do to... | Business Insider
- Microsoft is going to get more expensive for UK businesses... | Business Insider